29182-87-4

Basic information

• Product Name: 2-BROMO-N-(4-METHOXY-PHENYL)-ACETAMIDE
• Synonyms: CHEMBRDG-BB 4023667;2-BROMO-N-(4-METHOXY-PHENYL)-ACETAMIDE;AKOS BB/0110;AKOS BBB/462;2-bromo-N-(4-methoxyphenyl)acetamide(SALTDATA: FREE)
• CAS NO: 29182-87-4
• Molecular Formula: C₉H₁₀BrNO₂
• Molecular Weight: 244.09
• Mol File: 29182-87-4.mol
• Article Data: 42

Chemical Properties

• Boiling Point: 390.9°C at 760 mmHg
• Flash Point: 190.2°C
• Appearance: /
• Density: 1.528g/cm³
• Vapor Pressure: 2.57E-06mmHg at 25°C
• Refractive Index: 1.604
• Storage Temp.: -20°C Freezer
• Solubility: Methanol
• CAS DataBase Reference: 2-BROMO-N-(4-METHOXY-PHENYL)-ACETAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-N-(4-METHOXY-PHENYL)-ACETAMIDE(29182-87-4)
• EPA Substance Registry System: 2-BROMO-N-(4-METHOXY-PHENYL)-ACETAMIDE(29182-87-4)

Safety Data

• Hazardous Substances Data: 29182-87-4(Hazardous Substances Data)

Usage

Description

2-BROMO-N-(4-METHOXY-PHENYL)-ACETAMIDE is an organic compound characterized by its acetamide functional group and a bromo and methoxy substituent on the phenyl ring. It is known for its potential applications in the pharmaceutical and chemical industries due to its unique structural properties.

Uses

Used in Pharmaceutical Industry:
2-BROMO-N-(4-METHOXY-PHENYL)-ACETAMIDE is used as an intermediate compound for the synthesis of various antiviral and antibacterial agents. Its chemical structure allows for the development of new drugs that can target specific viral and bacterial pathogens, contributing to the fight against infectious diseases.
Used in Chemical Research:
In the field of chemical research, 2-BROMO-N-(4-METHOXY-PHENYL)-ACETAMIDE serves as a valuable building block for the creation of more complex molecules with potential applications in various industries. Its unique structure makes it a versatile compound for further chemical modifications and exploration of new properties.

InChI:InChI=1/C9H10BrNO2/c1-13-8-4-2-7(3-5-8)11-9(12)6-10/h2-5H,6H2,1H3,(H,11,12)

Upstream product

• 104-94-9 4-methoxy-aniline 
• 79-08-3 bromoacetic acid 
• 598-21-0 2-Bromoacetyl bromide 
• 22118-09-8 2-bromoacetyl chloride 

Downstream Products

• 1019401-00-3 1-[(4-methoxy-phenylcarbamoyl)-methyl]-5-methyl-1H-pyrazole-3-carboxylic acid ethyl ester 
• 1019400-01-1 C₁₆H₁₉N₃O₄ 
• 1393743-02-6 N-hydroxy-4-{[(4-methoxyphenylcarbamoylmethyl)amino]methyl}benzamide 
• 51-66-1 4-methoxyacetanilide 
• 24043-42-3 diethyl 1-(4-methoxyphenyl)-4-oxoazetidine-2,2-dicarboxylate 

Relevant articles and documents

Design, synthesis, in vitro antiproliferative evaluation and in silico studies of new VEGFR-2 inhibitors based on 4-piperazinylquinolin-2(1H)-one scaffold

Angiogenesis is essential in the growth of solid tumors which need oxygen and nutrients supply to grow in size. The VEGF/VEGFR-2 signaling pathway plays an important role in tumor angiogenesis. Sorafenib is an FDA approved cancer therapeutic with activity

Facile synthesis, antimicrobial evaluation and molecular docking studies of pyrazole-imidazole-triazole hybrids

A series of eighteen pyrazole-imidazole-triazole hybrid (2-(4-((2-(substituted-1H-pyrazol-1-yl)-4-phenyl-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)-N-(substituted)phenylacetami- de) (6a-6r) are synthesized through click reaction between in situ gener

Synthesis and Cytotoxic Evaluation of Some New 1,2,3-Triazole Linked 2-Imino-4-(Trifuoromethyl)-Thiazolidin-4-ol Derivatives

A new series of 1,2,3-triazole tagged 2-imino-4-(trifluoromethyl)thiazolidinol derivatives was synthesized through click chemistry under Sharpless conditions and evaluated for anticancer activity against human monocytic leukemia (U937), human breast adeno